The Foundation of Lily Benthine Lund Report issue

Foundation

Organization Overview

First Clinical Trial
1998
NCT01819649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

The Lily Benthine Lunds Foundation

Active Ingredients

Drugs in Other Trials (2)

4-aminopyridine (1 trial)

high-selenium yeast (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2